Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01469
|
|||||
| Drug Name |
Exatecan mesylate
|
|||||
| Synonyms |
Exatecan mesylate; DX-8951; DX-8951a; DX-8951f; UM-1; UM-2
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Pancreatic cancer [ICD11: 2C10] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C25H26FN3O7S
|
|||||
| Canonical SMILES |
CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O.CS(=O)(=O)O
|
|||||
| InChI |
InChI=1S/C24H22FN3O4.CH4O3S/c1-3-24(31)14-6-18-21-12(8-28(18)22(29)13(14)9-32-23(24)30)19-16(26)5-4-11-10(2)15(25)7-17(27-21)20(11)19;1-5(2,3)4/h6-7,16,31H,3-5,8-9,26H2,1-2H3;1H3,(H,2,3,4)/t16-,24-;/m0./s1
|
|||||
| InChIKey |
BICYDYDJHSBMFS-GRGFAMGGSA-N
|
|||||
| CAS Number |
CAS 169869-90-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 531.6 | Topological Polar Surface Area | 169 | ||
| Heavy Atom Count | 37 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | |||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00023972) Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | |||||
| 2 | Pharmacogenomic importance of ABCG2. Pharmacogenomics. 2008 Aug;9(8):1005-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.